Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Target discretionary areas first, compare frequent bills, and negotiate rates to reduce outflows while maintaining needs.
14,378 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Plug Power stock popped after-hours following a strong Q4 showing and raised 2026 guidance. This article breaks down ...
Stocks moved sharply in both directions on Tuesday as investors weighed the risk of broader conflict in the Middle Ea...
Nvidia has delivered one of the era's most dramatic stock ascents. But with such gains already in the price, can the ...
BTCC’s TradFi platform has surpassed $200 million in cumulative volume since its February launch, triggering a March ...
Choosing a long term crypto strategy can be tough. This guide compares Bitcoin and Cardano to help you decide the bet...
Explore two powerful growth stories that fit the idea of brilliant growth stocks hold for the long term. NVIDIA leads...
Homes.com is elevating its challenge to Zillow in the online listing arena, raising the stakes for affordability. The...
A new study shows Gen Z is spending more than saving and delaying home ownership, signaling a broader shift in person...
New data shows a broad wave of exits ahead as U.S. founders prepare to monetize stakes. The multi-year shift could re...
A major investor sold a substantial stake in an Ethereum ETF, pulling out nearly $19 million in one trade. The move r...
This year’s top-performing Vanguard ETF grabbed headlines with eye-catching gains. Before you dive in, learn three re...